Literature DB >> 20683463

Intake of n-3 polyunsaturated fatty acids and non-alcoholic fatty liver disease: a cross-sectional study in Japanese men and women.

J Oya1, T Nakagami, S Sasaki, S Jimba, K Murakami, T Kasahara, T Wasada, H Sekiguchi, M Hasegawa, Y Endo, Y Iwamoto.   

Abstract

BACKGROUND/
OBJECTIVES: Non-alcoholic fatty liver disease (NAFLD) is a common condition, in which abnormal amounts of triglycerides accumulate in hepatocytes and is closely related to cardiovascular diseases and diabetes. Dietary fats contribute 15% of fat accumulation in the liver and regulate hepatic lipid metabolism. The supplementation of n-3 polyunsaturated fatty acids (n-3 PUFAs) improves NAFLD. The aim of this study is to assess the cross-sectional association between dietary n-3 PUFAs and NAFLD in Japanese men and women. SUBJECTS/
METHODS: Participants were middle-aged, apparently healthy, 296 men and 496 women, who did not drink alcohol and who participated in a general health check-up program. Dietary information from the previous month was obtained by the brief-type self-administered diet history questionnaire. NAFLD was diagnosed if abdominal ultrasonography revealed the presence of fatty liver.
RESULTS: The prevalence of NAFLD was 45.3% in men and 17.5% in women. In comparison with the first tertile, multivariate adjusted odds ratios (95% confidence intervals) for the presence of NAFLD in the second and third tertiles for men taking eicosapentaenoic acid (EPA) were 0.59 (0.31-1.14) and 0.45 (0.23-0.90), respectively, (P for linear trend=0.024), and the multivariate adjusted odds ratios (95% confidence intervals) for the presence of NAFLD in the second and third tertiles for men taking EPA+docosahexaenoic acid (DHA) were 0.44 (0.23-0.86) and 0.48 (0.24-0.95), respectively, (P for linear trend=0.035). However, there was no significant relation between NAFLD and each of these nutrients in women.
CONCLUSIONS: Dietary EPA and EPA+DHA may be independent and preventive nutrients for NAFLD in Japanese men.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20683463     DOI: 10.1038/ejcn.2010.139

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  20 in total

1.  A short-term n-3 DPA supplementation study in humans.

Authors:  Eliza Miller; Gunveen Kaur; Amy Larsen; Su Peng Loh; Kaisa Linderborg; Harrison S Weisinger; Giovanni M Turchini; David Cameron-Smith; Andrew J Sinclair
Journal:  Eur J Nutr       Date:  2012-06-23       Impact factor: 5.614

2.  Erythrocyte membrane n-3 polyunsaturated fatty acids are inversely associated with the presence and progression of nonalcoholic fatty liver disease in Chinese adults: a prospective study.

Authors:  Zhan-Yong Chen; Meng Liu; Li-Peng Jing; Mian-Li Xiao; Hong-Li Dong; Geng-Dong Chen; Yu-Ming Chen
Journal:  Eur J Nutr       Date:  2019-04-01       Impact factor: 5.614

3.  Menhaden oil decreases high-fat diet-induced markers of hepatic damage, steatosis, inflammation, and fibrosis in obese Ldlr-/- mice.

Authors:  Christopher M Depner; Moises Torres-Gonzalez; Sasmita Tripathy; Ginger Milne; Donald B Jump
Journal:  J Nutr       Date:  2012-06-27       Impact factor: 4.798

Review 4.  Practical Dietary Recommendations for the Prevention and Management of Nonalcoholic Fatty Liver Disease in Adults.

Authors:  Elena S George; Adrienne Forsyth; Catherine Itsiopoulos; Amanda J Nicoll; Marno Ryan; Siddharth Sood; Stuart K Roberts; Audrey C Tierney
Journal:  Adv Nutr       Date:  2018-01-01       Impact factor: 8.701

5.  Low docosahexaenoic acid content in plasma phospholipids is associated with increased non-alcoholic fatty liver disease in China.

Authors:  Ju-Sheng Zheng; Amei Xu; Tao Huang; Xiaomei Yu; Duo Li
Journal:  Lipids       Date:  2012-04-19       Impact factor: 1.880

6.  Epidemiology of a fast emerging disease in the Asia-Pacific region: non-alcoholic fatty liver disease.

Authors:  Chan Wah-Kheong; Goh Khean-Lee
Journal:  Hepatol Int       Date:  2012-06-15       Impact factor: 6.047

7.  Chronic HCV infection was associated with severe insulin resistance and mild atherosclerosis: a population-based study in an HCV hyperendemic area.

Authors:  Ichiro Miyajima; Takumi Kawaguchi; Ako Fukami; Yumiko Nagao; Hisashi Adachi; Satoshi Sasaki; Tsutomu Imaizumi; Michio Sata
Journal:  J Gastroenterol       Date:  2012-06-08       Impact factor: 7.527

Review 8.  Role of diet and lifestyle changes in nonalcoholic fatty liver disease.

Authors:  William Nseir; Elias Hellou; Nimer Assy
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

9.  Docosahexaenoic acid ameliorates palmitate-induced lipid accumulation and inflammation through repressing NLRC4 inflammasome activation in HepG2 cells.

Authors:  Xiaoqin Luo; Yan Yang; Tianran Shen; Xilan Tang; Yunjun Xiao; Tangbin Zou; Min Xia; Wenhua Ling
Journal:  Nutr Metab (Lond)       Date:  2012-04-19       Impact factor: 4.169

10.  Multidisciplinary pharmacotherapeutic options for nonalcoholic Fatty liver disease.

Authors:  Kei Nakajima
Journal:  Int J Hepatol       Date:  2012-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.